RYANE PASSNO: Open Payments
NPI 1407239478 · MOLINE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,359 in 60 payments from 12 companies in 2025. Trend: 2023 $797 · 2024 $1,282 · 2025 $1,359
Food & beverage: $1,359
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $407 |
| ABBVIE INC. | 10 | $207 |
| Lilly USA, LLC | 8 | $152 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $127 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $111 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $104 |
| Novo Nordisk Inc | 4 | $92 |
| Amgen Inc. | 3 | $59 |
| PFIZER INC. | 2 | $42 |
| Exact Sciences Corporation | 1 | $20 |
Products named: FARXIGA, JARDIANCE, VRAYLAR, Kerendia, CAPLYTA, MOUNJARO, EVENITY, QULIPTA.
Industry payments across IL — which companies pay providers there.
